Once established the potential benefit of c-Src inhibition in GBM and considering the pro-tumoral role of autophagy in established tumors, we decided to investigate the role of TAT-Cx43266-283, a c-Src inhibitor, in GSC autophagy. The gene discussed is SRC; the disease is glioblastoma.